BioSpace News Archive

Aurora Cannabis Inc. today announced that it has scheduled its conference call to discuss the results for its first quarter ended September 30, 2018.

Following comments today from Alex Azar, the Secretary of Health and Human Services, on an alternative payment model for radiation oncology, the American Society for Radiation Oncology (ASTRO) issued the following statement from CEO Laura Thevenot

Vanda Pharmaceuticals Inc. today announced that it will participate at the following upcoming investor conferences in November 2018

295 Regenerative Medicine Clinical Trials Now Supported by Cryoport; 38 Programs in Phase III

Quarterly GAAP revenues of $32.4 million and net loss attributable to Intrexon of $57.3 million including non-cash charges of $38.7 million

Today at the 28th Diabetes Technology Meeting (DTM), Ascensia Diabetes Care has for the first time presented clinical research demonstrating that use of the CONTOUR®DIABETES app can reduce the chances of hypoglycemic and hyperglycemic events in people with diabetes.

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2018.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) today announced that it has entered into a multi-year agreement with The Brink’s Company (NYSE: BCO) through its Brink’s Canada subsidiary to provide secure logistics and cash management services for Canopy Growth’s domestic and international cannabis operations.

Omeros Corporation today announced its intention to offer, subject to market and other conditions, $210 million aggregate principal amount of its Convertible Senior Notes due 2023 (the “Notes”) in a private offering (the “Offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933

Eli Lilly and Company will participate in the Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13, 2018. Enrique Conterno, senior vice president of Lilly and president of Lilly Diabetes and Lilly USA, will participate in a fireside chat at 3:40 p.m., Eastern Time.